Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine

BACKGROUND: Little is known about the safety of SARS-CoV-2 vaccination in patients with rheumatic musculoskeletal disease (RMD). We evaluated the occurrence of adverse events following immunization (AEFI) in RMD patients and heathy subjects who received anti-SARS-CoV-2 mRNA vaccine. METHODS: We perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinelli, Francesca Romana, Favalli, Ennio Giulio, Garufi, Cristina, Cornalba, Martina, Colafrancesco, Serena, Conti, Fabrizio, Caporali, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748531/
https://www.ncbi.nlm.nih.gov/pubmed/35016701
http://dx.doi.org/10.1186/s13075-021-02674-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748531/
https://www.ncbi.nlm.nih.gov/pubmed/35016701
http://dx.doi.org/10.1186/s13075-021-02674-w

Ejemplares similares